Skip to main content

‘QQQA’ Won’t Miss Its Shot as Pfizer and Moderna Set to Profit with Boosters

Analysts and healthcare investors estimate that Moderna and Pfizer will earn billions from Covid-19 boosters in the coming months and set the stage for a booster market that would be similar to the $6 billion annual flu vaccine market, as reported in Reuters. The companies have been anticipating...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.